Keyword Search
Legend:
CC = Vancouver Convention Centre F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: study design returned 22 record(s)
|
|
Monday, 07/30/2018
|
Assessing Treatment Benefit in Patient-Centric Study Designs
Jagadish Gogate, Johnson & Johnson-Janssen R&D
|
Leveraging Multiple Study Designs and Statistical Methods to Evaluate Comparative Effectiveness of Asthma Medications
Tebeb Gebretsadik, Vanderbilt University Medical Center; Pingsheng Wu, Vanderbilt University; Rees L Lee, U. S. Navy; Amber M Evans, Health ResearchTX LLC; Tan Ding, Vanderbilt University Medical Center; Nicholas M Sicignano, Health Research Tx ; Ann Wu, Harvard Medical School; Carlos Iribarren, Kaiser Permanente Division of Research; Butler Melissa, Kaiser Permanente; Chang Yu, Vanderbilt University Medical Center; William Dupont, Vanderbilt University Medical Center; Christina Fox, Health ResearchTx; Tina V Hartert, Vanderbilt University Medical Center
|
Improving the Design of Pragmatic Clinical Trials Using Data Collected from Electronic Medical Records
Susan Shortreed, Kaiser Permanente Washington Health Research Institute; Carlyn M Rutter, RAND Corporation; Andrea J. Cook, Kaiser Permanente Washington Health Research Institute; Greg Simon, Kaiser Permenete Washington Health Research Insitute
9:15 AM
|
Epidemiological Modeling to Guide Efficacy Study Design Evaluating Vaccines to Prevent Emerging Diseases
An Vandebosch, Janssen; Joris Menten, Janssen ; Guillermo Herrera-Taracena, Janssen
11:35 AM
|
Leveraging Multiple Study Designs and Statistical Methods to Evaluate Comparative Effectiveness of Asthma Medications
Tebeb Gebretsadik, Vanderbilt University Medical Center; Pingsheng Wu, Vanderbilt University; Rees L Lee, U. S. Navy; Amber M Evans, Health ResearchTX LLC; Tan Ding, Vanderbilt University Medical Center; Nicholas M Sicignano, Health Research Tx ; Ann Wu, Harvard Medical School; Carlos Iribarren, Kaiser Permanente Division of Research; Butler Melissa, Kaiser Permanente; Chang Yu, Vanderbilt University Medical Center; William Dupont, Vanderbilt University Medical Center; Christina Fox, Health ResearchTx; Tina V Hartert, Vanderbilt University Medical Center
11:45 AM
|
|
Tuesday, 07/31/2018
|
Comparison of Group Testing Algorithms for Clustered Data
Ana Best, NIH NCI DCEG Biostatistics Branch; Paul S Albert, National Cancer Institute; Yaakov Malinovsky, University of Maryland Baltimore County Dept. of Mathematics and Statistics
|
Addressing Challenges in an International Study with Propensity Scores: a Case Study from Indonesia
Marissa Gargano, RTI International; Susan Edwards, RTI International
|
Addressing Challenges in an International Study with Propensity Scores: a Case Study from Indonesia
Marissa Gargano, RTI International; Susan Edwards, RTI International
8:45 AM
|
Comparison of Group Testing Algorithms for Clustered Data
Ana Best, NIH NCI DCEG Biostatistics Branch; Paul S Albert, National Cancer Institute; Yaakov Malinovsky, University of Maryland Baltimore County Dept. of Mathematics and Statistics
9:30 AM
|
Methods and Study Design for Integrating External Controls with Allele Frequencies
Megan Sorenson, University of Colorado Denver; Audrey Hendricks, University of Colorado - Denver
10:05 AM
|
If it Is in the Electronic Health Record, Then it Must Be True
Jareen Meinzen-Derr, Cincinnati Children's Hospital Med Center
2:05 PM
|
Evaluation of Therapeutic Effect in Clinical Study Using Companion Diagnostic Device for Patient Screening
Jeng Mah, Beckman Coulter
3:05 PM
|
|
Wednesday, 08/01/2018
|
A Novel Blind Start Study Design to Investigate Vestronidase Alfa for Mucopolysaccharidosis VII, an Ultra-Rare Genetic Disease
Wenjie Song, Ultragenyx Pharmaceutical Inc; Chao-Yin Chen, Ultragenyx Pharmaceutical Inc; Christine Haller, Ultragenyx Pharmaceutical Inc; Emil Kakkis, Ultragenyx Pharmaceutical Inc
|
A Novel Blind Start Study Design to Investigate Vestronidase Alfa for Mucopolysaccharidosis VII, an Ultra-Rare Genetic Disease
Wenjie Song, Ultragenyx Pharmaceutical Inc; Chao-Yin Chen, Ultragenyx Pharmaceutical Inc; Christine Haller, Ultragenyx Pharmaceutical Inc; Emil Kakkis, Ultragenyx Pharmaceutical Inc
8:40 AM
|
Deep Learning in Medical Imaging: Evaluation and Study Design
Robyn Ball, Stanford University; David Larson, Stanford University; Pranav Rajpurkar, Stanford University; Matthew Chen, Nines AI; Jeremy Irvin, Stanford University; Jaden Yang, Stanford University; Matthew P Lungren, Stanford University
9:20 AM
|
Longitudinal Parametric Dose-Response Surface Model Assisted Early Phase Study Design
Yongming Qu, Eli Lilly and Company
9:50 AM
|
Adaptive Multi-Combination Platform Trials in Oncology; Considerations for Study Designs
Stuart Bailey, Novartis Institutes for Biomed Research; Jennifer Gauvin, Novartis
9:55 AM
|
|
|
